# Contact Tesa Peptides: The Tesamorelin Digest Editors

> Contact the editors of Tesa Peptides, an independent tesamorelin research digest. Send corrections, source questions, or citation suggestions. Not a clinic and not a vendor.

Questions about a source, a correction to flag, or a study we missed — reach the editors here.

## Reach the Editors

Tesa Peptides is an editorial project covering the tesamorelin research literature. Use the form below to send a correction, ask about a citation, or suggest a study we should add to the digest. We read every message and update the record where a source warrants it.

We are not a clinic and not a vendor. We cannot answer questions about obtaining, dosing, or using tesamorelin or any other compound, and we do not provide medical advice — those questions belong with a qualified healthcare professional. What we can help with is the published literature: what a study measured, where a figure comes from, and how to read it.

## What to Expect

Messages about sources, citations, and factual corrections get priority — accuracy is the whole point of this project, and a well-sourced correction will change the page. If you flag a claim, a pointer to the study or document helps us verify it quickly.

We do not collect personal health information, and we have no products, prices, or orders to discuss. This contact channel exists for editorial matters only: the science of tesamorelin as the peer-reviewed record describes it, and the accuracy of how we have summarized it here.

---

The tesamorelin literature laid out as a study syllabus — the GHRH-analogue peptide and its visceral-fat trials walked step by connected step, each figure tagged to its study and the FDA-approved-for-HIV-lipodystrophy-only scope posted at the head of the path; a research curriculum, not a clinic, a vendor, or a prescription.